Koninklijke Philips N.V.

PHG Healthcare Medical Devices

Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.

Revenue
+0.55%
EPS
−85.0%
Free cash flow
+154.2%
Total debt
−4.96%

Quarter to September 2026, against a year earlier

30.29 0.22 −0.72%
Market cap
$29.8B
P/E
25.8×
Fwd P/E
11.2×
Dividend yield
3.33%
F-score
7/9
Altman Z
1.98
Beneish M
−2.68
Dividend safety
55/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

24.87 22.85 19.86 20.67
P/S ratio
1.27 1.28 1.26 1.16
P/FCF ratio
44.24 14.78 14.05 11.28
P/Operating CF
16.23 118.50 59.63 38.55
P/B ratio
2.07 1.95 1.95 1.79
EV/Sales
1.50 1.52 1.51 1.39
EV/EBITDA
10.50 10.26 9.19 9.23
EV/FCF
52.15 17.59 16.85 13.56
Current Ratio
1.32 1.32 1.26 1.33
Net Debt/EBITDA
5.15 8.34 4.51 10.12
Debt/Equity
0.63 0.60 0.55 0.60
Earnings Yield
4.02% 4.38% 5.03% 4.84%
Free Cash Flow Yield
2.26% 6.76% 7.12% 8.86%
Free Cash Flow per Share
1.46 0.03 0.27 0.45
Book value per Share
13.11 14.04 13.96 13.67
Free Cash Flow
1,384.61 32.77 259.07 440.20
EV/EBIT
18.79 17.93 15.71 16.04
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026